Surgery Partners CS (SGRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 317,900 | 92,700 | 184,300 | 174,914 | 69,699 |
| Receivables | 382,200 | 326,900 | 307,600 | 288,023 | 220,594 |
| Inventories | 56,400 | 46,300 | 43,400 | 44,951 | 28,777 |
| Other current assets | 27,400 | 41,800 | 36,800 | 38,502 | 0 |
| TOTAL | $801,500 | $525,500 | $588,300 | $563,225 | $361,955 |
| Non-Current Assets | |||||
| PPE Net | 544,600 | 523,300 | 426,300 | 398,536 | 204,253 |
| Investments And Advances | 90,300 | 93,200 | 78,500 | 74,282 | 34,980 |
| Intangibles | 3,514,900 | 3,449,700 | 3,437,100 | 3,405,746 | 1,603,227 |
| Other Non-Current Assets | 461,900 | 427,200 | 146,100 | 180,984 | 100,543 |
| TOTAL | $4,611,700 | $4,493,400 | $4,088,000 | $4,059,548 | $1,943,003 |
| Total Assets | $5,413,200 | $5,018,900 | $4,676,300 | $4,622,773 | $2,304,958 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 64,400 | 56,000 | 55,600 | 58,726 | 27,822 |
| Accounts payable and accrued liabilities | 100,200 | 96,700 | 83,300 | 84,710 | 49,766 |
| Accrued Expenses | 175,200 | 54,200 | 55,200 | 49,625 | 29,273 |
| Other current liabilities | 217,000 | 191,200 | 155,200 | 109,944 | 79,864 |
| TOTAL | $556,800 | $398,100 | $349,300 | $303,005 | $186,725 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,792,400 | 2,524,700 | 2,270,900 | 2,130,556 | 1,414,421 |
| Other Non-Current Liabilities | 630,000 | 597,800 | 487,800 | 440,096 | 181,157 |
| TOTAL | $3,539,800 | $3,242,400 | $2,868,800 | $2,652,352 | $1,793,559 |
| Total Liabilities | $4,096,600 | $3,640,500 | $3,218,100 | $2,955,357 | $1,980,284 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,860 | 49,290 | 48,801 | 48,612 | 48,625 |
| Common Shares | 500 | 500 | 500 | 487 | 485 |
| Retained earnings | -431,800 | -315,700 | -247,000 | -41,316 | -311,351 |
| Other shareholders' equity | 1,140,000 | 1,030,900 | 1,031,200 | 1,012,685 | 314,997 |
| TOTAL | $1,316,600 | $1,378,400 | $1,458,200 | $1,667,416 | $324,674 |
| Total Liabilities And Equity | $5,413,200 | $5,018,900 | $4,676,300 | $4,622,773 | $2,304,958 |